1. Home
  2. IBRX vs AWI Comparison

IBRX vs AWI Comparison

Compare IBRX & AWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.26

Market Cap

8.4B

Sector

Health Care

ML Signal

HOLD

AWI

Armstrong World Industries Inc

HOLD

Current Price

$165.05

Market Cap

7.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBRX
AWI
Founded
2014
1860
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Plastic Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
7.0B
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
IBRX
AWI
Price
$7.26
$165.05
Analyst Decision
Strong Buy
Buy
Analyst Count
7
6
Target Price
$12.57
$208.50
AVG Volume (30 Days)
22.2M
502.3K
Earning Date
05-11-2026
04-28-2026
Dividend Yield
N/A
0.82%
EPS Growth
38.71
17.61
EPS
N/A
7.08
Revenue
$113,288,000.00
$1,620,800,000.00
Revenue This Year
$88.59
$10.25
Revenue Next Year
$131.15
$6.72
P/E Ratio
N/A
$23.34
Revenue Growth
668.31
12.11
52 Week Low
$1.83
$122.37
52 Week High
$12.43
$206.08

Technical Indicators

Market Signals
Indicator
IBRX
AWI
Relative Strength Index (RSI) 46.21 41.52
Support Level $5.89 $162.50
Resistance Level $8.28 $170.29
Average True Range (ATR) 0.94 4.19
MACD -0.21 0.73
Stochastic Oscillator 25.33 45.58

Price Performance

Historical Comparison
IBRX
AWI

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

About AWI Armstrong World Industries Inc

Armstrong World Industries Inc designs and manufactures exterior architectural applications, including ceilings, specialty walls, and exterior metal solutions, using materials such as mineral fiber, fiberglass, metal, felt, architectural resin and glass, wood, wood fiber, and glass-reinforced-gypsum. Its segments include Mineral Fiber, which produces suspended mineral fiber and fiberglass ceiling systems and includes results from the Worthington Armstrong Venture (WAVE) for ceiling suspension system (grid) products; Architectural Specialties, which designs, produces, and sources specialty ceilings, walls, and other architectural applications for commercial settings, with revenues mainly project driven; and Unallocated Corporate. The company operates in the United States and Canada.

Share on Social Networks: